Negative impactEconomy
Govt mandates manual verification of imported drugs and medical devices due to SWIFT 2.0 system gap
Economic Times 1 hr ago·6 Sept 2026, 6:45 pm
The government has ordered customs officials to manually verify import documents for all drugs and medical devices, even for shipments that were previously cleared automatically. This directive, issued on September 3, follows a gap identified in the SWIFT 2.0 digital system. Consequently, the standard risk-based clearance process has been paused to ensure regulatory compliance.
For investors, this development introduces a layer of uncertainty into the supply chain for pharmaceuticals. While the manual check is intended to maintain safety standards, it may lead to delays in the clearance of goods. This could impact the inventory levels of pharma companies and potentially affect their operational efficiency and revenue streams in the short term.
Market participants should watch for updates on when the SWIFT 2.0 system will be fully operational. Investors should also monitor any statements from major pharma companies regarding their logistics and how these new verification steps might impact their upcoming product launches or distribution timelines.
Excerpt from Economic Times
Customs officers must now manually check import documents for healthcare products. This manual verification applies even to facilitated imports cleared by the risk system. The Central Board of Indirect Taxes and Customs issued this directive on September third. A gap in the SWIFT 2.0 digital system necessitates this…Read the original at Economic Times
Key takeaways
- Category: Economy.
- AI reads the tone as negative (potentially bearish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.
